Biotechnology Venture Capital Firms
The world of biotechnology is one filled with unlimited potential and opportunities. Built upon transformative innovations that have the strength to redefine industries, it comes as no surprise that it stands as a powerful magnet for venture capital (VC) firms keen on investing in the future. Welcome to VC Firms List, the one-stop destination for all detailed information on biotechnology venture capital firms. As you explore, you will discover why we are the go-to website for anyone seeking insights into the VC firms and investors specializing in the biotechnology sector.
Read more
Company:
ShangBay Capital
Description: ShangBay Capital is a distinguished venture capital firm specializing in providing both U.S. and global investors with access to premier investment opportunities within the medical devices, biotechnology, and digital health sectors in the United States. The firm is committed to fostering early-stage venture equity participation, thereby supporting the growth of innovative companies in these dynamic fields. Since its inception in 2015, ShangBay Capital has successfully invested in more than 50 portfolio companies. Its notable achievements have been recognized in the venture capital space, as the firm was ranked as the Most Active Medical Device Venture Capitalist in both the U.S. and Europe during the years 2020 and 2021. Through its strategic investments and commitment to excellence, ShangBay Capital continues to play an influential role in advancing the frontiers of health technology and innovation.
Industry: Venture Capital and Private Equity
Founded: 2015
Domain: http://www.shangbaycapital.com/
Location: Palo Alto, California
Address: 1555 Alma Street, Palo Alto, California 94301, US
Size: 2-10 employees
Company:
Sherpa Healthcare Partners (夏尔巴投资)
Description: Sherpa Healthcare Partners (夏尔巴投资) is a distinguished venture capital and private equity firm founded by a highly experienced team of entrepreneurs. This team is dedicated to investing in and nurturing the growth of the pharmaceutical and biotech industries. Sherpa Healthcare Partners specializes in identifying and managing investments in leading companies and innovative startups across various sectors, including pharmaceuticals, gene technology, medical technology, and healthcare services.
The firm has successfully established a robust portfolio that fosters enduring value, collaborative partnerships, and strong relationships within the industry. Their commitment to building lasting connections allows them to provide comprehensive, all-cycle services that leverage essential resources for their portfolio companies. With a core team boasting over 15 years of experience in healthcare investment operations and management, Sherpa Healthcare Partners operates with shared values and deep mutual trust. Their complementary expertise enables them to navigate the complexities of the healthcare landscape effectively, positioning them as a reputable player in the venture capital and private equity arena focused on healthcare innovation.
Industry: Venture Capital and Private Equity
Founded: 2018
Domain: http://www.sherpavc.com.cn/
Location: Beijing, Beijing
Address: A0410, 4/F, Unit A, Huibin Building, No. 8. Beichen East Road, Chaoyang District, Beijing, Beijing 100029, CN
Size: 2-10 employees
Company:
Source Code Capital
Description: Source Code Capital is dedicated to establishing itself as the preferred partner for exceptional entrepreneurs who are at the forefront of contemporary business transformations and technological advancements. Founded in 2014, Source Code Capital currently manages approximately RMB 35 billion in assets, encompassing both RMB and USD investments. The firm adheres to a bottom-up approach rooted in fundamental analysis and thorough research to inform their investment strategies.
Since its inception, Source Code Capital has actively focused on investments that promote technological innovation and development. The firm is committed to supporting small and midsized enterprises, enhancing the livelihoods of individuals, and fostering green development, among other significant initiatives. Over the years, Source Code Capital has formed partnerships with more than 300 companies across a wide array of sectors, including Industrial Digitization, Artificial Intelligence, Robotics, Advanced Manufacturing, Green Development, Enterprise Software, Healthcare and Biotech, New Consumption and New Brands, as well as Global ventures.
The portfolio of Source Code Capital features a diverse family of companies, including notable names such as Bytedance, Meituan, KE Holdings Inc., Li Auto, RELX Technology, and others. This extensive lineup illustrates the firm’s active role in various innovative domains. Their investments also encompass firms like Baibu, XiaoYaoYao, Casstime, Ruigushop, YQNLink, Yijiupi, and Zhongneng United, along with emerging technology companies such as Hai Robotics, Chuxin, MechMind Robotics, and Keenon.
Source Code Capital has shown a strong commitment to backing cutting-edge firms, including Niu Technologies, Biren Technology, Silicon Integrated, GalaxySpace, and many others across diverse fields such as energy, technology, and biotech. In particular, the firm has made notable investments in companies like Unisun Energy, POWER OAK, Cloudgoing Technology, and various others that exemplify pioneering advancement.
Additionally, Source Code Capital takes pride in its innovative initiative, Code Class, which is a proprietary industry super hub. This unique community comprises over 300 entrepreneurs and expands to encompass broader partnerships, all aimed at creating substantial value within the entrepreneurial ecosystem. Through these efforts, Source Code Capital continues to play a pivotal role in fortifying technological growth and fostering entrepreneurial success within the sector.
Industry: Venture Capital and Private Equity
Founded: 2014
LinkedIn: https://www.linkedin.com/company/源码资本
Domain: http://www.sourcecodecap.com/
Location: 北京, 北京
Address: 北京市朝阳区望京东园七区保利国际广场塔1，26层, 北京, 北京 100102, CN
Size: 51-200 employees
Company:
Taiwania Capital
Description: Taiwania Capital is a distinguished venture capital firm that was established in August 2017 through a collaboration between the National Development Fund of the Executive Yuan of Taiwan and several private enterprises. The firm is dedicated to fostering partnerships with companies across the globe while simultaneously contributing to the economic development of Taiwan. Taiwania Capital concentrates its investments in startups that are based in either Taiwan or the United States, particularly those operating in the fields of technology and biotechnology. The firm is particularly interested in ventures that showcase disruptive and cutting-edge technologies.
The name "Taiwania Capital" is inspired by the Taiwania cryptomerioides, a remarkable tree species that was named after Taiwan in 1906. This tree can reach impressive heights of up to 90 meters, making it one of the tallest tree species in Asia, and it thrives within a rich and diverse ecosystem. Similarly, Taiwania Capital seeks to cultivate a robust ecosystem in Taiwan that is deeply rooted in entrepreneurial innovation. By effectively linking technology with capital, the firm aspires to accelerate the growth of groundbreaking enterprises and contribute positively to the business landscape in Taiwan and beyond.
Industry: Venture Capital and Private Equity
Founded: 2017
Domain: http://www.taiwaniacapital.com/
Location: Taipei, Taiwan
Address: No. 333, Section 1, Keelung Rd, Taipei, Taiwan 110, TW
Size: 51-200 employees
Company:
Tao Capital
Description: Tao Capital is a prominent venture capital firm based in China, dedicated to making significant investments in the healthcare, pharmaceutical, and biotechnology sectors. With a focus on identifying and nurturing innovative companies, Tao Capital plays a crucial role in advancing the development of cutting-edge solutions within these vital industries. Their investment strategy centers on partnering with forward-thinking entrepreneurs and visionary teams, fostering growth and enhancing value in the dynamic landscape of healthcare and biotechnology. By leveraging their extensive industry expertise and network, Tao Capital is committed to supporting the evolution of companies that are poised to make a meaningful impact on the health and wellness of populations in China and beyond.
Industry: Venture Capital and Private Equity
Founded: 2014
Domain: http://www.taocapital.cn/
Location: Bejing
Address: Beijing, Bejing, CN
Size: 11-50 employees
Company:
Tau Capital
Description: Tau Capital, headquartered in Abu Dhabi, UAE, is a distinguished entity within the venture capital and private equity sectors, committed to addressing the unprecedented challenges faced by today's world. The firm is dedicated to advancing technologies that not only reshape industries but also enhance global prosperity. Tau Capital specializes in early-stage investments, focusing on Seed, Series A, and Series B funding, particularly in high-impact sectors such as Artificial Intelligence, Biotechnology, Cybersecurity, and Sustainable Technologies. Additionally, the firm explores emerging fields that are poised to drive significant change, including Quantum Computing and Space.
Central to Tau Capital's mission is the aim to build enduring partnerships with entrepreneurs leading the way in innovation. The firm offers more than just financial backing; it provides access to a robust network of industry leaders and experts who deliver mentorship and strategic guidance. This support is designed to enhance the achievement of both entrepreneurial missions and strong financial outcomes. The firm employs a proprietary analytical framework, ensuring that its investment strategies are informed by strategic foresight and precision.
At Tau Capital, the philosophy transcends traditional investment approaches; the team views themselves as committed partners in the journey of innovation and growth. The firm invites collaboration, fostering an environment where together, they can shape the future and drive impactful advancements across various industries.
Industry: Venture Capital and Private Equity
Founded: 2023
Domain: http://www.taucapital.ae/
Location: Abu Dhabi
Address: Abu Dhabi, AE
Size: 2-10 employees
Company:
TauTona Group
Description: TauTona Group operates as a vertically integrated operational fund that specializes in the creation, investment, and development of innovative solutions within the fields of medtech, biotech, and regenerative medicine. The organization is committed to addressing unmet clinical needs in healthcare by fostering advancements that not only enhance patient outcomes but also promote cost efficiencies across the industry. With an unwavering belief that meaningful improvements in healthcare can be achieved through innovation, TauTona Group employs a sustainable investment model that enables the evaluation, design, testing, and development of disruptive ideas in a highly economical manner. This approach benefits all stakeholders involved—including inventors, investors, healthcare professionals, and, most importantly, patients.
Founded in 2010 by two esteemed professors and researchers from Stanford School of Medicine, TauTona Group has cultivated a strong focus on bioengineering, tissue regeneration, and stem cell therapeutic approaches. The expertise and vision of its founders have been instrumental in establishing the fund's commitment to driving progress and delivering impactful solutions in healthcare. Through their strategic initiatives and investments, TauTona Group continues to play a vital role in shaping the future of medical technology and regenerative medicine.
Industry: Venture Capital and Private Equity
Founded: 2010
Domain: http://www.tautonagroup.com/
Location: Redwood City, CA
Address: 604 Fifth Avenue, Suite D, Redwood City, CA 94063, US
Size: 11-50 employees
Company:
Tech Karma Investments
Description: Tech Karma Investments is a private fund dedicated to investing in technology startups that are poised to shape the future and contribute positively to society. The firm specializes in various innovative sectors, including Mobile Internet of Things (IoT), Artificial Intelligence (AI), Biotechnology, eCommerce, and Enterprise Software as a Service (SaaS). Although their current investment strategy is focused exclusively on opportunities within the United States, Tech Karma Investments remains committed to identifying and nurturing emerging companies that strive to enhance everyday life and create a better world. Through their strategic investments, the firm aims to foster advancements that will resonate across numerous industries and improve the overall quality of life.
Industry: Venture Capital and Private Equity
Founded: 2021
Domain: http://www.techkarma.us/
Location: Plano, TX
Address: Plano, TX 75093, US
Size: Self-employed
Company:
Two Bear Capital
Description: Two Bear Capital is a distinguished venture capital firm dedicated to investing in entrepreneurs who present innovative and transformative ideas within the realms of life sciences and technology. The firm is committed to creating a comprehensive ecosystem that fosters support, economic opportunity, and innovation. This vision is aimed at bringing to fruition the most impactful ideas, ultimately transforming them into long-lasting businesses that benefit society while also delivering value to investors.
Two Bear Capital primarily concentrates on early-stage, founder-led companies that are advancing disruptive innovations in a variety of sectors, including biotechnology, bioinformatics, healthcare information technology, machine learning, artificial intelligence, and information security. With a strategic presence across multiple key locations—including Menlo Park, San Diego, Boston, and New York—Two Bear Capital operates with its main office situated in Whitefish, Montana. The firm was established in 2019 by Mike Goguen and has since been positioned to make a significant impact in the venture capital and private equity landscape by supporting breakthrough ideas that drive meaningful change.
Industry: Venture Capital and Private Equity
Founded: 2019
Domain: http://www.twobearcapital.com/
Location: Whitefish, MT
Address: Whitefish, MT 59937, US
Size: 11-50 employees
Company:
Versant Ventures
Description: Versant Ventures is a prominent healthcare investment firm dedicated to supporting exceptional entrepreneurs in the development of the next generation of innovative companies. With a strong emphasis on biotechnology, Versant Ventures focuses on companies that are engaged in the discovery and development of novel therapeutics. Managing an impressive $2.4 billion in assets, the firm operates from multiple offices located in the United States, Canada, and Europe.
The team at Versant Ventures comprises professionals with extensive backgrounds in investment, operations, and clinical expertise, fostering a hands-on approach to company building. Since its inception in 1999, the firm has successfully contributed to the growth of over 70 companies, which have achieved significant milestones through acquisitions or initial public offerings (IPOs). Versant Ventures remains committed to its mission of empowering entrepreneurs and advancing healthcare innovation. For more information, interested parties can visit www.versantventures.com.
Industry: Venture Capital and Private Equity
Founded: 1999
Domain: http://www.versantventures.com/
Location: San Francisco, CA
Address: One Sansome Street, Suite 3630, San Francisco, CA 94104, US
Size: 11-50 employees
Company:
Viva BioInnovator
Description: Viva BioInnovator (VBI) serves as the specialized investment and incubation division of Viva Biotech Holdings, dedicated to the creation and development of biotech startups across a broad spectrum of indications and drug types. The company plays a vital role during the early stages of drug discovery, providing the necessary support to nurture and accelerate a startup's growth from initial concept to clinical program readiness.
Founded in 2014, VBI's innovative investment and incubation model emerged from a recognized need within the biotech sector. With its origins rooted in drug discovery services, the company operates cutting-edge, proprietary drug discovery platforms that are globally recognized for their excellence. As VBI engaged with large pharmaceutical clients worldwide, it observed a substantial demand from numerous entrepreneurs possessing promising ideas but lacking the necessary funding and data to move forward. Recognizing the potential in these innovative concepts, VBI adopted a proactive approach by offering not only operational support through its contract research organization (CRO) drug discovery services but also financial backing to assist talented scientists in their journey from concept to reality.
VBI's unique "equity for service" (EFS) investment and incubation model has thus become a cornerstone of its operations. Headquartered in Shanghai, the company has a presence in Boston and maintains staff in California, allowing it to leverage a broad network of resources and partnerships. As of early 2019, VBI has invested in over 30 companies sourced from the hundreds of proposals submitted to it for evaluation. The company is committed to continuing its rapid investment pace in the coming years, with a portfolio that primarily includes U.S.-based enterprises. However, VBI remains open to global proposals and is eager to explore innovative ideas that align with its investment strategy.
For more information about Viva BioInnovator, interested parties are encouraged to visit their website at www.vivabioinnovator.com or to reach out via email at innovation@vivabiotech.com. To learn more about their parent organization, Viva Biotech, the website www.vivabiotech.com provides additional insights.
Industry: Venture Capital and Private Equity
Founded: 2014
Domain: http://www.vivabioinnovator.com/
Location: Shanghai, Shanghai
Address: 334 Aidisheng Road, Shanghai, Shanghai 201203, CN
Size: 11-50 employees
Company:
Westlake Village BioPartners
Description: Westlake Village BioPartners is a distinguished venture capital and private equity firm that plays a pivotal role in fostering the development of the burgeoning biotech community in Los Angeles. By leveraging their extensive experience and connections from Silicon Valley, the firm contributes significantly to the biopharma industry, which is characterized by its innovative, unconventional, and dynamic nature. Westlake Village BioPartners is committed to catalyzing advancements not only within the Los Angeles area but also on a broader scale, recognizing that transformative technologies can emerge from diverse sources. The firm adeptly aligns its company-building expertise with the aspirations of entrepreneurs and academic institutions, facilitating the growth of groundbreaking initiatives in biotechnology.
Industry: Venture Capital and Private Equity
Founded: 2018
Domain: http://www.westlakebio.com/
Location: Westlake Village, California (CA)
Address: 3075 Townsgate Road, Suite 140, Westlake Village, California (CA) 91361, US
Size: 2-10 employees
Company:
World Ventures
Description: World Ventures is a distinguished global venture builder and startup investor, established in 2022 with the objective of developing impactful ventures over the coming years. The company engages in a comprehensive search for the next big opportunities that can make a significant difference in various industries. Comprising a team of entrepreneurs and co-founders, World Ventures is dedicated to transforming innovative visions into tangible realities and exceptional enterprises.
The company focuses on building and investing in businesses that have the potential to drive positive change in the world. Their areas of interest span a diverse range of sectors, including renewable energy, climate technology, new space exploration, biotechnology, genomics, health technology, agri-tech, property technology, the circular economy, next-generation materials, e-commerce, and the sharing economy.
World Ventures typically prefers to engage with startups at the pre-seed and seed stages, adopting a hands-on approach that underscores their commitment to the success of the ventures they support. The company provides seed capital and emphasizes an unlimited investment horizon, which allows for substantial growth potential. They leverage their extensive expertise and robust network to foster the development and scalability of successful businesses. As co-founders, they partner closely with entrepreneurs to help them realize their ambitions.
Additionally, World Ventures specializes in venture building, technology transfer, and offering Venture Capital as a Service (VCaaS), positioning themselves as a valuable ally to innovative startups on their growth journey.
Industry: Venture Capital and Private Equity
Founded: 2022
Domain: http://www.worldventures.vc/
Location: Bratislava
Address: Bratislava, SK
Size: 2-10 employees
Company:
Ysios Capital
Description: Ysios Capital is a prominent Spanish venture capital firm that specializes in providing private equity financing to early and mid-stage life science companies engaged in developing disruptive therapeutic products and innovative platform technologies. Established in 2008, Ysios Capital has successfully managed over USD 420 million across three dedicated funds focused on life sciences. The firm is guided by a team of seasoned professionals with extensive experience in building and nurturing biotech companies, positioning Ysios Capital as a key player in the investment landscape of the life sciences sector. With its strategic approach and commitment to fostering innovation, Ysios Capital continues to contribute significantly to the advancement of transformative healthcare solutions.
Industry: Venture Capital and Private Equity
Founded: 2008
Domain: http://www.ysioscapital.com/
Location: San Sebastián, País Vasco / Euskadi
Address: Avenida de la Libertad, 25, 4 planta, San Sebastián, País Vasco / Euskadi 20004, ES
Size: 11-50 employees